YTHDC1 and nonpapillary renal cell carcinoma: Li et al. [128] reported that the YY1/HDAC2 complex in ccRCC inhibited the expression of YTHDC1, thereby affecting the expression of its downstream target gene ANXA1 and inhibiting the sensitivity of ccRCC to tyrosinase inhibitors.